Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heparin and heparan sulfate-like glycosaminoglycans (HS-GAGs) are complex, linear polysaccharides found on cell surfaces and within the extracellular matrix [2][4]. They are characterized by a high negative charge density due to extensive sulfation, which allows them to interact with a vast array of proteins, including coagulation factors, growth factors, and chemokines [3]. In clinical medicine, heparin and its low-molecular-weight derivatives are gold-standard anticoagulants that function by binding to antithrombin III, significantly accelerating the inactivation of thrombin and Factor Xa [1]. Beyond their role in hematology, HS-GAGs act as essential co-receptors in various cell signaling pathways and serve as primary attachment sites for numerous pathogens, including viruses like SARS-CoV-2 and Herpes Simplex Virus [3]. Their structural diversity and ubiquity make them critical regulators of physiological processes such as angiogenesis, wound healing, and the inflammatory response [2].
Drugs targeting these molecules primarily act by potentiating antithrombin III to accelerate the inhibition of coagulation factors like Thrombin (Factor IIa) and Factor Xa, or by competitively inhibiting the binding of endogenous ligands and pathogens to the glycosaminoglycan chains [1][3].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heparin and heparan sulfate-like glycosaminoglycans (HS-GAGs).